Welcome to the Emmes Data Management Center’s home page for HIV Vaccine Trials Network (HVTN) experimental medicine clinical trials.


The HVTN’s mission is to fully characterize the safety, immunogenicity, and efficacy of HIV vaccine candidates with the goal of developing a safe, effective vaccine as rapidly as possible for prevention of HIV infections globally.
The HVTN experimental medicine program focuses on developing and implementing early-phase clinical trials testing first-in-human vaccine reagents designed to induce neutralizing antibody responses.

For more information about the HVTN please visit the HVTN website (https://www.hvtn.org/en.html.)